Nano Labs Ltd NA · NASDAQ
$1.52 +0.66% (+$0.01)
Summary
40 / 100 · Bulios Score
What speaks for it
- Out of every 100 CNY of revenue, 502 CNY is left as net profit.
- The share price is below the Bulios Fair Price.
What to watch
- Revenue fell by 70% a year over the last 3 years.
- It reports a profit, yet spends more cash than it brings in.
- It passes only 3 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 5.0 CNY for 1 CNY of yearly profit.
Valuation in detailIs it growing?
It is shrinkingRevenue (CNY)
Diluted EPS (CNY)
Revenue grew by 66% a year over 5 years. Over the last 3 years it fell by 70% a year.
Growth in detailDoes it make money?
Income figures for the last 12 months are not available.
Profitability in detailIs it financially healthy?
Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 18
- Hold 5
- Sell 0
No analyst has published a price target.
78% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Product 99%
- Service 1.4%
By region
- HONG KONG 100%
Product brings in 99% of revenue.
Segments in detail